2.5 Million Cataract Surgery Eye Drop Vials Recalled: FDA

Source Summary

Concerns that a Lupin prescription eye drop may contain foreign substance led Lupin Pharmaceuticals Inc. of Naples, Florida to initiate the voluntary withdrawal.